(Press-News.org) National Institutes of Health researchers and collaborators have discovered over 100 new regions of the human genome, also known as genomic loci, that appear to influence a person’s blood pressure. Results of the study also point to several specific genomic loci that may be relevant to iron metabolism and a type of cellular receptor known as adrenergic receptors.
The study, published in Nature Genetics, is one of the largest such genomic studies of blood pressure to date, including data from over 1 million participants and laying the groundwork for researchers to better understand how blood pressure is regulated. Such insights could point to potential new drug targets.
“Our study helps explain a much larger proportion of the differences between two people’s blood pressure than was previously known,” said Jacob Keaton, Ph.D., staff scientist in the Precision Health Informatics Section within the National Human Genome Research Institute’s (NHGRI) Intramural Research Program and first author of the study. “Our study found additional genomic locations that together explain a much larger part of the genetic differences in people’s blood pressure. Knowing a person's risk for developing hypertension could lead to tailored treatments, which are more likely to be effective.”
To understand the genetics of blood pressure, the researchers combined four large datasets from genome-wide association studies of blood pressure and hypertension. After analyzing the data, they found over 2,000 genomic loci linked to blood pressure, including 113 new regions. Among the newly discovered genomic loci, several reside in genes that play a role in iron metabolism, confirming previous reports that high levels of accumulated iron can contribute to cardiovascular disease.
The researchers also confirmed the association between variants in the ADRA1A gene and blood pressure. ADRA1A encodes a type of cell receptor, called an adrenergic receptor, that is currently a target for blood pressure medication, suggesting that other genomic variants discovered in the study may also have the potential to be drug targets to alter blood pressure.
"This study shows that these big genome-wide association studies have clinical relevance for finding new drug targets and are needed to discover more drug targets as we go forward,” said Dr. Keaton.
From these analyses, the researchers were able to calculate a polygenic risk score, which combines the effects of all genomic variants together to predict blood pressure and risk for hypertension. These risk scores consider which genomic variants confer risk for hypertension and reveal clinically meaningful differences between people’s blood pressure.
Polygenic risk scores have potential to serve as a useful tool in precision medicine, but more diverse genomic data is needed for them to be applicable broadly in routine health care. While the collected data was mostly from people of European ancestry (due to limited availability of diverse datasets when the study was started), the researchers found that the polygenic risk scores were also applicable to people of African ancestry, which was confirmed through analyzing data from NIH’s All of Us Research Program, a nationwide effort to build one of the largest biomedical data resources and accelerate research to improve human health.
Nearly half of adults in the United States have high blood pressure, known as hypertension. High blood pressure often runs in families, meaning that there is a genetic component to developing the condition in addition to environmental contributions such as a high-salt diet, lack of exercise, smoking and stress. When blood pressure is consistently too high, it can damage the heart and blood vessels throughout the body, increasing a person’s risk for heart disease, kidney disease, stroke and other conditions.
The project was led by researchers at NHGRI in collaboration with Queen Mary University of London, Vanderbilt University Medical Center, Nashville, Tennessee, the University of Groningen in the Netherlands and other institutions, as part of the International Consortium of Blood Pressure. Over 140 investigators from more than 100 universities, institutes and government agencies contributed to this international study.
END
Scientists discover over 100 new genomic regions linked to blood pressure
NIH-led study finds genetic markers that explain up to 12% of the differences between two people’s blood pressure
2024-04-30
ELSE PRESS RELEASES FROM THIS DATE:
Researchers identify over 2,000 genetic signals linked to blood pressure in study of over one million people
2024-04-30
The Queen Mary-led study reveals the most detailed picture yet of genetic contributors to blood pressure. The findings lead to improved polygenic risk scores, which will better predict blood pressure and risk for hypertension.
Researchers led by Queen Mary University of London and supported by the National Institute for Health and Care Research (NIHR) have discovered over a hundred new regions of the human genome, also known as genomic loci, that appear to influence a person’s blood pressure. In total, over 2,000 independent genetic signals for blood pressure are now reported, demonstrating that blood pressure is a highly complex trait influenced by thousands ...
Scientists find cancer-like features in atherosclerosis, spurring opportunity for new treatment approaches
2024-04-30
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease. Atherosclerosis is characterized by a narrowing of arterial walls and can increase risk of coronary artery disease, stroke, peripheral artery disease, or kidney disorders. The findings, supported by the National Institutes of Health (NIH), could pave the way for the use of anti-cancer drugs to counteract the tumor-like mechanisms ...
A virus could help save billions of gallons of wastewater produced by fracking
2024-04-30
EL PASO, Texas (April 30, 2024) – An estimated 168 billion gallons of wastewater — or produced water — is generated annually by the Permian Basin fracking industry, according to a 2022 report by the Texas Produced Water Consortium. The major waste stream has proved both difficult and costly to treat because of the chemical complexity of the water.
In a new study published in the journal Water, researchers at The University of Texas at El Paso have identified a novel means of treating the wastewater generated by oil and gas production: bacteriophages.
Ramón Antonio Sánchez, a doctoral candidate within UTEP’s chemistry ...
MSD joins the Open Targets consortium
2024-04-30
Open Targets, a public-private partnership dedicated to pre-competitive drug discovery research, today announced MSD, the tradename of Merck & Co., Inc., Rahway, N.J., USA, as the latest partner to join the consortium. Open Targets aims to accelerate the development of safe and effective medicines by leveraging cutting-edge technologies to identify, prioritise, and validate potential drug targets. MSD’s expertise in drug discovery will complement the strengths of the current partners: EMBL’s European Bioinformatics Institute (EMBL-EBI), the Wellcome Sanger Institute, GSK, Sanofi, Pfizer, and Genentech, ...
U of T researchers target neurogenesis in new approach to treat Parkinson’s disease
2024-04-30
Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons depleted in Parkinson’s disease, pointing toward a new approach for a disease with no cure and few effective treatments.
The researchers used an antibody to selectively activate a receptor in a molecular signaling pathway to develop dopaminergic neurons. These neurons produce dopamine, a neurotransmitter critical to brain health.
Researchers around the world have been working to coax stem cells to differentiate into dopaminergic ...
Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
2024-04-30
Leuven (Belgium) 30/04/2024 - For the first time, researchers from VIB-KU Leuven, UZ Leuven, Janssen Pharmaceutica and multiple international collaborators have introduced quantitative methods and extensive confounder control to discover microbiome biomarkers in colorectal cancer development. While multiple microbial taxa have been put forward as potential cancer-associated biomarkers in the past, this new study uncovers obscured contributions that may have resulted in incorrect associations. The results have been published in Nature Medicine.
Cancer ...
Unveiling nature's custodians: groundbreaking study highlights crucial role of scavengers in wetlands
2024-04-30
A pioneering study highlights the importance of carrion and scavengers in wetlands on a global scale. A study by researchers from the Ecology area of the Miguel Hernández University of Elche (UMH) and the Ecology department of the University of Alicante (UA) reveals the fundamental importance of scavengers and carrion in wetlands. The article, published in Biological Reviews, emphasizes that the benefits provided by scavengers far outweigh the potential drawbacks. Among their essential functions are the recycling and transportation of nutrients and the regulation of water quality, benefiting the entire ecosystem, from soil and plants to birds and mammals.
Historically, ...
Data scarcity challenges identification of endocrine disruptors
2024-04-30
As a result, the researchers recommend updating the information requirements in the EU legislation, REACH. They also propose various approaches for evaluating chemical substances to ensure that all available information is fully utilized.
Researchers from DTU National Food Institute and the University of Southern Denmark have screened the scientific literature for the Danish Environmental Protection Agency to find substances showing signs of endocrine disrupting properties and thus being potentially harmful to humans and ...
A significant portion of the world’s population continues to trust vaccines, says survey in 23 countries
2024-04-30
A substantial proportion of the world’s population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world’s population. The study, published in Nature Medicine, was co-led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by “la Caixa” Foundation, and the Graduate School of Public Health and Health Policy of the City University of New York (CUNY SPH).
The severe human impact of the COVID-19 pandemic led to the rapid research and development of safe and effective vaccines based on existing models, ...
Clumps of this molecule inhibit strep’s DNA-cleaving enzymes
2024-04-30
An entirely new approach to inhibiting DNA-cleaving enzymes works through the aggregation of an otherwise non-toxic molecule. This Kobe University discovery may lead to a much-needed method for curbing Streptococcus growth.
Enzymes are the body’s tools to make almost all reactions happen. But the same is true for bacteria like Streptococcus, which causes toxic shock syndrome, a rapidly progressing and deadly condition. When the body’s white blood cells try to capture the bacteria by casting nets made out ...
LAST 30 PRESS RELEASES:
New research boosts future whooping cough vaccines
Mechanistic understanding could enable better fast-charging batteries
No bones about it: new details about skeletal cell aging revealed
UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue
UMaine research examines best methods for growing Atlantic sea scallops
Medical cannabis could speed recovery, especially at community recovery homes
Study assesses U.S. image amid weakening of democracy
Two scientific researchers to receive 2025 Ralph L. Sacco Scholarships for Brain Health
Researchers improve chemical reaction that underpins products from foods to fuels
Texas Tech to develop semiconductor power devices through $6 million grant
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
Hot Schrödinger cat states created
How cells repair their power plants
Oxygen is running low in inland waters—and humans are to blame
ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain
Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity
How a small number of mutations can fuel outbreaks of western equine encephalitis virus
Exposure to wildfire smoke linked with worsening mental health conditions
Research uncovers hidden spread of one of the most common hospital-associated infections
Many older adults send their doctors portal messages, but who pays?
Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits
Gender inequity in institutional leadership roles in US academic medical centers
Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations
Rare combination of ovarian tumors found in one patient
AI-driven clinical recommendations may aid physician decision making to improve quality of care
Artificial intelligence has potential to aid physician decisions during virtual urgent care
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
New study reveals polymers with flawed fillers boost heat transfer in plastics
Signs identified that precede sudden arrhythmic death syndrome in young people
Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance
[Press-News.org] Scientists discover over 100 new genomic regions linked to blood pressureNIH-led study finds genetic markers that explain up to 12% of the differences between two people’s blood pressure